Z51 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Type 1 excludes for Z51 ICD 10 code
- follow-up examination after treatment (Z08-Z09)
Codes
- Z51.0 Encounter for antineoplastic radiation therapy
- Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy
- Z51.11 Encounter for antineoplastic chemotherapy
- Z51.12 Encounter for antineoplastic immunotherapy
- Z51.5 Encounter for palliative care
- Z51.6 Encounter for desensitization to allergens
- Z51.8 Encounter for other specified aftercare
- Z51.81 Encounter for therapeutic drug level monitoring
- Z51.89 Encounter for other specified aftercare
Possible back-references that may be applicable or related to Z51 ICD10 Code:
- Z00-Z99 Factors influencing health status and contact with health services
- Z40-Z53 Encounters for other specific health care
Present On Admission (POA Exempt)
Z51 ICD 10 code is considered exempt from POA reporting